Evaluating bleeding severity in immune thrombocytopenia (ITP)

Annals of Hematology

Volumn 89, Issue SUPPL. 1, 2010, Pages

  Neunert, Cindy E ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Bleeding severity; Immune thrombocytopenia; Outcome measures

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; RHESUS D ANTIBODY;

BLEEDING; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL RESEARCH; DISEASE SEVERITY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; REVIEW; THROMBOCYTE COUNT; TREATMENT OUTCOME; VALIDITY; CHILD; COMPLICATION; HEMORRHAGE; PATHOPHYSIOLOGY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEVERITY OF ILLNESS INDEX;

CHILD; HEMORRHAGE; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77955661462     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0930-4     Document Type: Review

References (21)

1. JS Lilleyman 1999 Management of childhood idiopathic thrombocytopenic purpura Br J Haematol 105 871 875 10.1111/j.1365-2141.1999.01409.x 1:STN:280:DC%2BD3c%2FitFaltA%3D%3D 10554795
2. JN George SH Woolf GE Raskob JS Wasser LM Aledort PJ Ballem VS Blanchette JB Bussel DB Cines JG Kelton AE Lichtin R McMillan JA Okerbloom DH Regan I Warrier 1996 Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology Blood 88 3 40 1:CAS:528:DyaK28XjvFSnsLo%3D 8704187
3. OB Eden JS Lilleyman 1992 Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group Arch Dis Child 67 1056 1058 10.1136/adc.67.8.1056 1:STN:280:DyaK38zptF2kug%3D%3D 1520013
4. D De Mattia D Del Principe GC Del Vecchio M Jankovic A Arrighini P Giordano A Menichelli P Mori M Zecca A Pession 2000 Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica Haematologica 85 420 424 10756369
5. CE Neunert GR Buchanan P Imbach PH Bolton-Maggs CM Bennett EJ Neufeld SK Vesely L Adix VS Blanchette T Kuhne 2008 Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura Blood 112 4003 4008 10.1182/blood-2008-03-138487 1:CAS:528:DC%2BD1cXhsVSmsr3N 18698007
6. AR Gaines 2005 Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura Blood 106 1532 1537 10.1182/blood-2004-11-4303 1:CAS:528:DC%2BD2MXps1Ogs7Y%3D 15878975
7. GR Buchanan L Adix R Klaassen E Neufeld S Zimmerman K Stine 2004 Quantitative assessment of drug treatment side effects in children with idiopathic thrombocytopenic purpura (ITP) Blood 104 3030
8. SH O'Brien AK Ritchey KJ Smith 2007 A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP) Pediatr Blood Cancer 48 173 180 10.1002/pbc.20830 16550529
9. Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, Neufeld EJ, Buchanan GR, Silva MP, Chan AK,Young NL (2007) Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools. J Pediatr 150:510-515, 515 e511
10. F Rodeghiero R Stasi T Gernsheimer M Michel D Provan DM Arnold JB Bussel DB Cines BH Chong N Cooper B Godeau K Lechner MG Mazzucconi R McMillan MA Sanz P Imbach V Blanchette T Kuhne M Ruggeri JN George 2009 Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2386 2393 10.1182/blood-2008-07-162503 1:CAS:528:DC%2BD1MXjsFKhurs%3D 19005182
11. GR Buchanan L Adix 2002 Grading of hemorrhage in children with idiopathic thrombocytopenic purpura J Pediatr 141 683 688 10.1067/mpd.2002.128547 12410198
12. PH Bolton-Maggs I Moon 1997 Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines Lancet 350 620 623 10.1016/S0140-6736(97)04143-3 1:STN:280:DyaK2svjsVWmug%3D%3D 9288044
13. LK Page B Psaila D Provan J Michael Hamilton JM Jenkins AS Elish ML Lesser JB Bussel 2007 The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP Br J Haematol 138 245 248 10.1111/j.1365-2141.2007.06635.x 17542983
14. CM Bennett ZR Rogers DD Kinnamon JB Bussel DH Mahoney TC Abshire H Sawaf TB Moore ML Loh BE Glader MC McCarthy BU Mueller TA Olson AN Lorenzana WC Mentzer GR Buchanan HA Feldman EJ Neufeld 2006 Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura Blood 107 2639 2642 10.1182/blood-2005-08-3518 1:CAS:528:DC%2BD28XjtlKltbk%3D 16352811
15. KB Meyer KA Clayton 2009 Measurement and analysis of patient-reported outcomes Methods Mol Biol 473 155 169 19160737
16. DM Gregory CY Way 2009 Qualitative research in clinical epidemiology Methods Mol Biol 473 203 215 19160740
17. D Barnard M Woloski D Feeny P McCusker J Wu M David J Bussel J Lusher C Wakefield S Henriques V Blanchette 2003 Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents J Pediatr Hematol Oncol 25 56 62 10.1097/00043426-200301000-00011 12544774
18. S von Mackensen C Nilsson M Jankovic N Mirra E D'Angelo A Borkhardt R Ljung 2006 Development of a disease-specific quality of life questionnaire for children and adolescents with idiopathic thrombocytopenic purpura (ITP-QoL) Pediatr Blood Cancer 47 688 691 10.1002/pbc.20977
19. SD Mathias JB Bussel JN George R McMillan GJ Okano JL Nichol 2007 A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation Health Qual Life Outcomes 5 11 10.1186/1477-7525-5-11 17316442
20. SD Mathias SK Gao KL Miller D Cella C Snyder R Turner A Wu JB Bussel JN George R McMillan DK Wysocki JL Nichol 2008 Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective Health Qual Life Outcomes 6 13 10.1186/1477-7525-6-13 18261217
21. SD Mathias SK Gao M Rutstein CF Snyder AW Wu D Cella 2009 Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences Curr Med Res Opin 25 375 383 10.1185/03007990802634119 19192982